231 related articles for article (PubMed ID: 22228338)
1. Comparison between endoscopic macroscopic classification and F-18 FDG PET findings in gastric mucosa-associated lymphoid tissue lymphoma patients.
Hirose Y; Kaida H; Ishibashi M; Uozumi J; Arikawa S; Kurata S; Hayabuchi N; Nakahara K; Ohshima K
Clin Nucl Med; 2012 Feb; 37(2):152-7. PubMed ID: 22228338
[TBL] [Abstract][Full Text] [Related]
2. Mucosa-associated lymphoid tissue lymphoma studied with FDG-PET: a comparison with CT and endoscopic findings.
Enomoto K; Hamada K; Inohara H; Higuchi I; Tomita Y; Kubo T; Hatazawa J
Ann Nucl Med; 2008 May; 22(4):261-7. PubMed ID: 18535876
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG uptake and its clinical relevance in primary gastric lymphoma.
Yi JH; Kim SJ; Choi JY; Ko YH; Kim BT; Kim WS
Hematol Oncol; 2010 Jun; 28(2):57-61. PubMed ID: 19593742
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Positron Emission Tomography/Computed Tomography in Gastric Mucosa-associated Lymphoid Tissue Lymphoma.
Hwang JW; Jee SR; Lee SH; Kim JH; Seol SY; Lee SM
Korean J Gastroenterol; 2016 Apr; 67(4):183-8. PubMed ID: 27112244
[TBL] [Abstract][Full Text] [Related]
5. Detection rate of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta-analysis.
Treglia G; Zucca E; Sadeghi R; Cavalli F; Giovanella L; Ceriani L
Hematol Oncol; 2015 Sep; 33(3):113-24. PubMed ID: 25047160
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic role of 18F-FDG PET in gastric MALT lymphoma.
Ambrosini V; Rubello D; Castellucci P; Nanni C; Farsad M; Zinzani P; Alavi A; Tehranipour N; Al-Nahhas A; Fanti S
Nucl Med Rev Cent East Eur; 2006; 9(1):37-40. PubMed ID: 16791802
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of baseline
Albano D; Bosio G; Camoni L; Farina M; Re A; Tucci A; Giubbini R; Bertagna F
Hematol Oncol; 2019 Feb; 37(1):39-46. PubMed ID: 30299563
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience.
Albano D; Bertoli M; Ferro P; Fallanca F; Gianolli L; Picchio M; Giubbini R; Bertagna F
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):589-597. PubMed ID: 27619357
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary mucosa-associated lymphoid tissue lymphoma:
Albano D; Borghesi A; Bosio G; Bertoli M; Maroldi R; Giubbini R; Bertagna F
Br J Radiol; 2017 Nov; 90(1079):20170311. PubMed ID: 28830222
[TBL] [Abstract][Full Text] [Related]
10. 18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference.
Hoffmann M; Wöhrer S; Becherer A; Chott A; Streubel B; Kletter K; Raderer M
Ann Oncol; 2006 Dec; 17(12):1761-5. PubMed ID: 16980600
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type.
Hoffmann M; Kletter K; Diemling M; Becherer A; Pfeffel F; Petkov V; Chott A; Raderer M
Ann Oncol; 1999 Oct; 10(10):1185-9. PubMed ID: 10586335
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary mucosa-associated lymphoid tissue lymphoma: computed tomography and ¹⁸F fluorodeoxyglucose-positron emission tomography/computed tomography imaging findings and follow-up.
Zhang WD; Guan YB; Li CX; Huang XB; Zhang FJ
J Comput Assist Tomogr; 2011; 35(5):608-13. PubMed ID: 21926857
[TBL] [Abstract][Full Text] [Related]
13. Does Delayed-Time-Point Imaging Improve 18F-FDG-PET in Patients With MALT Lymphoma?: Observations in a Series of 13 Patients.
Mayerhoefer ME; Giraudo C; Senn D; Hartenbach M; Weber M; Rausch I; Kiesewetter B; Herold CJ; Hacker M; Pones M; Simonitsch-Klupp I; Müllauer L; Dolak W; Lukas J; Raderer M
Clin Nucl Med; 2016 Feb; 41(2):101-5. PubMed ID: 26402137
[TBL] [Abstract][Full Text] [Related]
14. Significance of (18)F-2-deoxy-2-fluoro-glucose accumulation in the stomach on positron emission tomography.
Takahashi H; Ukawa K; Ohkawa N; Kato K; Hayashi Y; Yoshimoto K; Ishiyama A; Ueki N; Kuraoka K; Tsuchida T; Yamamoto Y; Chino A; Uragami N; Fujisaki J; Igarashi M; Fujita R; Koyama M; Yamashita T
Ann Nucl Med; 2009 Jun; 23(4):391-7. PubMed ID: 19399579
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma.
Perry C; Herishanu Y; Metzer U; Bairey O; Ruchlemer R; Trejo L; Naparstek E; Sapir EE; Polliack A
Eur J Haematol; 2007 Sep; 79(3):205-9. PubMed ID: 17662066
[TBL] [Abstract][Full Text] [Related]
16. 18F-Fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography in mucosa-associated lymphoid tissue lymphoma: variation in 18F-FDG avidity according to site involvement.
Park SH; Lee JJ; Kim HO; Lee DY; Suh C; Jung HY; Choi KD; Kim DH; Huh J; Ryu JS
Leuk Lymphoma; 2015; 56(12):3288-94. PubMed ID: 25804932
[TBL] [Abstract][Full Text] [Related]
17. Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation.
Park YJ; Hyun SH; Moon SH; Lee KH; Min BH; Lee JH; Kim WS; Kim SJ; Choi JY
Sci Rep; 2021 Apr; 11(1):9243. PubMed ID: 33927319
[TBL] [Abstract][Full Text] [Related]
18. SUVmax/THKmax as a biomarker for distinguishing advanced gastric carcinoma from primary gastric lymphoma.
Fu L; Li H; Wang H; Xu B; Fan Y; Tian J
PLoS One; 2012; 7(12):e50914. PubMed ID: 23226547
[TBL] [Abstract][Full Text] [Related]
19. F-18 FDG PET/CT evaluation of radiotherapy response in rare case of mucosa-associated lymphoid tissue lymphoma.
Minamimoto R; Tateishi U; Tomita N; Inayama Y; Omura-Minamisawa M; Tayama Y; Hata M; Kubota Y; Inoue T
Ann Nucl Med; 2010 Feb; 24(2):115-9. PubMed ID: 20077163
[TBL] [Abstract][Full Text] [Related]
20. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma.
Hoffmann M; Kletter K; Becherer A; Jäger U; Chott A; Raderer M
Oncology; 2003; 64(4):336-40. PubMed ID: 12759529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
